MiNK Therapeutics, Inc. (INKT)
(Delayed Data from NSDQ)
$14.72 USD
-0.44 (-2.90%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $14.93 +0.21 (1.43%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
MiNK Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
INKT 14.72 -0.44(-2.90%)
Will INKT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INKT based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for INKT
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report | INKT ...
12 Health Care Stocks Moving In Tuesday's Intraday Session
INKT: Analyst Downgrades MiNK Therapeutics to Neutral | INKT Stock News
MiNK Therapeutics (INKT) Downgraded to Neutral Amidst Valuation Concerns | INKT Stock News
MiNK Therapeutics (INKT) Downgraded by Analyst with Price Target Set | INKT Stock News